Cargando…
Immunohistochemistry as an accurate tool for the assessment of BRAF V600E and TP53 mutations in primary and metastatic melanoma
Metastatic melanoma is a fatal disease with poor prognosis. Ever since targeted therapy against oncogenic BRAF was approved, molecular profiling has become an integral part of the management of such patients. While molecular testing is not available in all pathology laboratories, immunohistochemistr...
Autores principales: | Rusu, Stefan, Verocq, Camille, Trepant, Anne Laure, Maris, Calliope, De Nève, Nancy, Blanchard, Oriane, Van Campenhout, Claude, De Clercq, Sarah, Rorive, Sandrine, Cotoi, Ovidiu Simion, Decaestecker, Christine, Salmon, Isabelle, D'Haene, Nicky |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591695/ https://www.ncbi.nlm.nih.gov/pubmed/34790354 http://dx.doi.org/10.3892/mco.2021.2432 |
Ejemplares similares
-
Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients
por: Remmelink, Myriam, et al.
Publicado: (2020) -
IGF-IR: a new prognostic biomarker for human glioblastoma
por: Maris, C, et al.
Publicado: (2015) -
Design and Validation of a Gene-Targeted, Next-Generation Sequencing Panel for Routine Diagnosis in Gliomas
por: D’Haene, Nicky, et al.
Publicado: (2019) -
The Prognostic Value of the Combination of Low VEGFR-1 and High VEGFR-2 Expression in Endothelial Cells of Colorectal Cancer
por: D’Haene, Nicky, et al.
Publicado: (2018) -
The Role of SMAD4 Inactivation in Epithelial–Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link?
por: Racu, Marie-Lucie, et al.
Publicado: (2022)